20^th European Gastroenterology and Therapeutics Congress

Liver Diseases and Hepatology

This session focuses on the evolving landscape of liver diseases and hepatology, covering common and complex conditions such as hepatitis, fatty liver disease (NAFLD/NASH), cirrhosis, and liver cancer. Liver health is increasingly affected by metabolic syndrome, alcohol use, viral infections, and autoimmune conditions, making timely diagnosis and targeted treatment more critical than ever. Innovations in liver imaging (like elastography and FibroScan), non-invasive biomarkers, and genetic testing are improving early detection of liver fibrosis and cirrhosis. Therapeutic advances, including antiviral therapies for hepatitis B and C, novel agents for NASH, and immunotherapies for hepatocellular carcinoma, are enhancing patient survival and quality of life. The session will also highlight the role of liver transplantation, donor optimization, and regenerative medicine, including bioengineered liver tissue and stem cell therapy. A multidisciplinary and preventive approach, coupled with personalized medicine, is now central to managing liver diseases in both acute and chronic stages.